Research suggests that blood tests may be able to detect early, subtle cognitive decline associated with Alzheimer's disease. These tests, which involve blood biomarkers, may be able to identify signs of cognitive decline in midlife that are tied to an increased risk of Alzheimer's. The development of such blood tests is showing promise, with several studies indicating their potential to predict dementia years before symptoms appear.